Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation.
We previously reported that oxidized low-density lipoprotein and one of its constituents, lysophosphatidylcholine (lysoPC), caused smooth muscle cell proliferation that was inhibitable by vitamin E and by a neutralizing antibody against basic fibroblast growth factor-2 (FGF-2). We now show that the mitogenic activity of lysolipids is highly dependent on structure. Phospholipids with palmitoyl fatty acid and phosphocholine induced DNA synthesis optimally. Shorter and longer fatty acids were significantly less potent, as were phosphoserine and phosphoethanolamine head groups. Structurally related phospholipids [platelet-activating factor (PAF) and lysoPAF] were also mitogens and acted via an analogous FGF-2-dependent, vitamin E-inhibitable mechanism. The mechanism of lysoPC stimulation was distinct from that of another phospholipid mitogen, lysophosphatidic acid (lysoPA), in that lysoPC stimulation was not pertussis toxin inhibitable. Furthermore, lysoPA stimulation was not inhibitable by vitamin E. Despite its distinct cellular pathway for stimulation, lysoPA also ultimately led to FGF-2 release. Our data show that specific structural attributes of lysoPC, PAF, and lysoPAF enable these agents to mediate smooth muscle cell release of FGF-2, which in turn stimulates proliferation.
Chai
Y C
YC
Department of Cell Biology, Lerner Research Institute of the Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Binion
D G
DG
Chisolm
G M
GM
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D005227:Fatty Acids / Q000032:analysis; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D006801:Humans; D008246:Lysophospholipids / Q000737:chemistry* / Q000494:pharmacology*; D008934:Mitogens / Q000494:pharmacology; D015394:Molecular Structure; D009130:Muscle, Smooth / Q000737:chemistry*; D019308:Palmitic Acid / Q000032:analysis; D010743:Phospholipids / Q000494:pharmacology; D010767:Phosphorylcholine / Q000032:analysis; D011817:Rabbits; D013329:Structure-Activity Relationship; D014810:Vitamin E / Q000494:pharmacology
D005227:Fatty Acids; D008246:Lysophospholipids; D008934:Mitogens; D010743:Phospholipids; D016222:Fibroblast Growth Factor 2; D010767:Phosphorylcholine; D014810:Vitamin E; D019308:Palmitic Acid; D004247:DNA